Aghazadeh Behzad (CIK 1701815) reported 3 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-07-28). Recent activity: Buy SCTX (2.3M shares), Buy SCTX (50,000 shares), Buy SCTX (7,905 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-28 | Scribe Therapeutics, Inc. (SCTX) | Director | Buy | 2.3M | $35.0M |
| 2026-07-28 | Scribe Therapeutics, Inc. (SCTX) | Director | Buy | 50,000 | $1.1M |
| 2026-07-28 | Scribe Therapeutics, Inc. (SCTX) | Director | Buy | 7,905 | $144,266 |
Source: SEC Form 4 filings · as of 2026-07-28